Hem › Hypofarynxcancer › New Jersey › Edison
Kliniska studier för Hypofarynxcancer i Edison, NJ
4 studier för Hypofarynxcancer söker deltagare vid platser i och runt Edison (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekryterarFas 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekryterarFas 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekryterarFas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RekryterarFas 2
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
Hypofarynxcancer-studier i andra städer
- Atlanta, GA6 studier
- Chicago, IL6 studier
- Joliet, IL5 studier
- Milwaukee, WI5 studier
- Peoria, IL5 studier
- Stevens Point, WI5 studier
- Cape Girardeau, MO5 studier
- Wausau, WI5 studier
- Bloomington, IL5 studier
- Richmond, VA5 studier
- Kansas City, MO5 studier
- Evanston, IL4 studier
Andra studier i Edison
- Bröstcancer67 studier
- Icke-småcellig lungcancer48 studier
- Cancer (alla typer)34 studier
- Prostatacancer29 studier
- Lungcancer24 studier
- Kolorektal cancer23 studier
- Multipelt myelom22 studier
- Blåscancer21 studier
- Metastaserande cancer20 studier
- Akut myeloid leukemi20 studier
- Äggstockscancer20 studier
- Endometriecancer19 studier
Från ClinicalTrials.gov, data hämtad 7 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.